IPCA Laboratories Share Price

IPCA Laboratories Share Price

NSE: IPCALAB
|
Pharmaceuticals
|
S Cap
₹ 1,965.30
+₹9.20 (0.47%)
1D
Last updated 04 Sep, 2026, 15:29 IST

IPCA Laboratories Share Price Today

As of 5 Sep 2026, IPCA Laboratories share price is ₹1,965.30. The stock opened at ₹1,950.00, compared to its previous close of ₹1,956.10. During today's trading session, IPCA Laboratories share price moved in the range of ₹1,944.20 to ₹1,969.00, with an average price of ₹1,956.60 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,251.60 and a high of ₹2,001.50. On the performance front, IPCA Laboratories share price has increased by 33.20% over the last six months and is up 46.75% on a year-on-year basis.

₹1,944.20
0.47% up today
₹1,969.00
1D LOW
1D HIGH

IPCA Laboratories Returns Calculator

Circuit
L
H
₹1,572.30
₹2,358.30
52-week
L
H
₹1,251.60
₹2,001.50

About IPCA Laboratories

IPCA Laboratories Share Price
ISIN
INE571A01038
Sector Market Cap
₹ 49,855.4 Cr

Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.

IPCA Laboratories Financial Highlights

  • Revenue: IPCA Laboratories reported revenue of ₹9,820.78 crore in FY26 vs ₹9,032.39 crore in FY25. It showed an increase of 8.73% on a yearly basis.
  • Operating Profit: IPCA Laboratories reported an operating profit of ₹1,572.52 crore in FY26 vs ₹1,131.14 crore in FY25. It showed an increase of 39.02% on a year-on-year basis.
  • Net Profit: IPCA Laboratories reported a net profit of ₹1,191.37 crore in FY26 vs ₹787.53 crore in FY25. It showed an increase of 51.28% on a yearly basis.

IPCA Laboratories Quarterly Result Highlights

  • IPCA Laboratories reported revenue of ₹2,813.36 crore in Jun 2026, compared with ₹2,482.22 crore in Mar 2026, representing an increase of 13.34% on a quarter-on-quarter (QoQ) basis.
  • IPCA Laboratories reported an operating profit of ₹572.08 crore in Jun 2026, compared with ₹404.45 crore in Mar 2026, representing an increase of 41.45% on a quarter-on-quarter (QoQ) basis.
  • IPCA Laboratories reported a profit of ₹422.81 crore in Jun 2026, compared with ₹309.40 crore in Mar 2026, reflecting an increase of 36.65% on a QoQ basis.
  • The earnings per share (EPS) of IPCA Laboratories stood at ₹44.98 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
44.72%
FII
10.73%
Other DII
6.22%
Retail and other
7.18%
Mutual funds
31.15%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 202510.43%
Dec 202510.63%
Mar 202610.63%
Jun 202610.73%
Mkt Cap Cr
49,855.40
P/E
36.26
P/B
6.18
ROE
14.15%
D/E
0.04
ROCE
18.58%
Div. Yield
0.31%
EPS(TTM)
45.84
Turnover
0.79
EV/EBITDA
21.57
Net Margin
15.44%
Op. Margin
25.17%
ROA
11.15%
Quick Ratio
1.61
Curr. Ratio
3.21
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Ipca Labs. outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Ipca Labs. appears to be fairly valued compared to its peers
Step 5 of 5
Earnings
Excellent
Ipca Labs. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,55,634.0037.605.4513.74%0.6117.33%93.240.84%0.4810.90
Divis Laboratories2,41,576.0082.5914.4115.32%0.0019.56%629.490.33%0.5598.19
Torrent Pharmaceuticals1,84,478.0085.5721.9425.49%1.6913.85%222.760.70%0.4958.70
Zydus Lifesciences1,11,820.0024.354.1218.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.343.2511.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs99,417.5091.1818.7616.77%0.4016.14%97.200.11%0.6713.72
Lupin96,528.8017.394.3023.76%0.0424.88%659.000.85%0.57129.18
Mankind Pharma96,179.6046.525.9011.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories96,322.1030.262.5311.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma95,127.2025.642.519.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

IPCA Laboratories Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹9,646.33₹8,939.59₹7,705.04₹6,244.32
Other Income₹174.45₹92.80₹124.77₹125.62
Total Revenue₹9,820.78₹9,032.39₹7,829.81₹6,369.94
Total Expenses₹8,161.83₹7,696.20₹6,879.39₹5,624.65
Profit Before Tax₹1,572.52₹1,131.14₹842.67₹745.29
Tax₹381.15₹343.61₹313.46₹253.36
Profit After Tax₹1,191.37₹787.53₹529.21₹491.93
EPS - Basic₹44.98₹29.08₹21.57₹18.58
EPS - Diluted₹44.98₹29.08₹21.57₹18.58

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,572.52₹1,131.14₹842.67₹745.29
Income before WC changes₹1,849.87₹1,859.03₹1,332.54₹980.47
Change in Assets-₹280.16-₹192.84-₹185.45₹88.73
Change in Liabilities-₹13.79₹16.38₹93.86-₹39.74
Change in WC-₹293.95-₹176.46-₹91.59₹48.99
Cash flow from Operations₹1,141.97₹1,321.32₹944.65₹805.81
Cash flow from Investing-₹246.77-₹869.50-₹1,291.79-₹725.00
Cash flow from Financing-₹753.53-₹282.98-₹552.55₹507.24
Total Cash Flow₹141.67₹168.84-₹899.69₹588.05
Cash (Start of the year)₹924.63₹755.79₹1,578.98₹990.93
Cash (End of the year)₹1,066.30₹924.63₹755.79₹1,578.98

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹5,996.58₹5,793.51₹5,565.73₹3,437.16
Current Assets₹6,373.61₹5,967.04₹5,535.55₹5,189.27
Total Assets₹12,370.19₹11,760.55₹11,101.28₹8,626.43
Current Liabilities₹2,306.93₹2,386.22₹2,355.64₹1,805.82
Net Current Asset₹4,066.68₹3,580.82₹3,179.91₹3,383.45
Non-Current Liabilities₹539.20₹986.06₹1,018.64₹905.29
Equity Capital₹9,524.06₹8,388.27₹7,727.00₹5,915.32
Total Equity & Liabilities₹12,370.19₹11,760.55₹11,101.28₹8,626.43

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹7,336.75₹6,677.92₹6,166.46₹5,814.62
Other Income₹94.64₹71.29₹111.29₹111.19
Total Revenue₹7,431.39₹6,749.21₹6,277.75₹5,925.81
Total Expenses₹5,868.84₹5,467.90₹5,322.23₹5,175.32
Profit Before Tax₹1,532.13₹999.77₹822.16₹750.49
Tax₹399.61₹349.01₹291.75₹244.79
Profit After Tax₹1,132.52₹650.76₹530.41₹505.70
EPS - Basic₹44.64₹25.65₹20.91₹19.93
EPS - Diluted₹44.64₹25.65₹20.91₹19.93

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,532.13₹999.77₹822.16₹750.49
Income before WC changes₹1,905.74₹1,605.55₹1,221.32₹956.58
Change in Assets-₹296.30₹43.76-₹160.96₹70.75
Change in Liabilities₹162.62₹49.51₹47.10-₹49.79
Change in WC-₹133.68₹93.27-₹113.86₹20.96
Cash flow from Operations₹1,378.12₹1,374.07₹830.51₹762.29
Cash flow from Investing-₹696.99-₹738.81-₹1,355.18-₹709.61
Cash flow from Financing-₹745.21-₹428.44-₹464.88₹506.38
Total Cash Flow-₹64.08₹206.82-₹989.55₹559.06
Cash (Start of the year)₹722.10₹515.28₹1,504.83₹945.77
Cash (End of the year)₹658.02₹722.10₹515.28₹1,504.83

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹5,780.50₹5,290.98₹5,149.38₹3,571.82
Current Assets₹3,995.00₹3,779.94₹3,509.89₹4,875.15
Total Assets₹9,775.50₹9,070.92₹8,659.27₹8,446.97
Current Liabilities₹1,418.75₹1,419.53₹1,520.17₹1,677.78
Net Current Asset₹2,576.25₹2,360.41₹1,989.72₹3,197.37
Non-Current Liabilities₹377.40₹759.77₹790.39₹891.89
Equity Capital₹7,979.35₹6,891.62₹6,348.71₹5,877.30
Total Equity & Liabilities₹9,775.50₹9,070.92₹8,659.27₹8,446.97
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
1965.3
13
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 13
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
65.01
Neutral
ATR (14)
47.86
Neutral
STOCH(9,6)
61.32
Neutral
STOCH RSI (14)
32.9
Neutral
ADX(9)
40.61
Bearish
UO(9)
54.93
Neutral
ROC(12)
3.24
Bullish
WillR(14)
-26.01
Neutral
Period
Simple value
Exponential vaue
5D
1968.08
1961.4
10D
1955.18
1945.09
20D
1888.24
1903.87
50D
1819.99
1818.15
100D
1691.7
1728.05
Volume trend — traded volume by day
4 Sep0L
3 Sep3L
2 Sep1L
1 Sep2L
31 Aug3L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
IPCA Laboratories Share Price
IPCA Laboratories
Pharmaceuticals
Add Stock
Add Another

IPCA Laboratories Share Price FAQs

IPCA Laboratories share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837